$ACBM
ACRO BIOMEDICAL CO., LTD.
CIK:0001622996|SEC Filings
Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Condensed Statements of Operations (Unaudited) | ||||
| Revenues | $ 0 | $ 0 | $ 0 | $ 0 |
| Operating expenses | ||||
| General and administrative | 17,554 | 13,614 | 77,825 | 22,548 |
| Total operating expenses | 17,554 | 13,614 | 77,825 | 22,548 |
| Loss from operations | (17,554) | (13,614) | (77,825) | (22,548) |
| Other income (expense) | ||||
| Liability forgiveness | 0 | 0 | 20,000 | 0 |
| Interest expense - related parties | (3,802) | (1,948) | (7,305) | (3,315) |
| Total other income (expense) | (3,802) | (1,948) | 12,695 | (3,315) |
| Net loss | $ (21,356) | $ (15,562) | $ (65,130) | $ (25,863) |
| Basic and diluted loss per share of common stock | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Weighted average number of shares of common stock outstanding | 60,042,000 | 60,042,000 | 60,042,000 | 60,042,000 |
Condensed Statements of Cash Flows (Unaudited) - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | $ (65,130) | $ (25,863) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Imputed interest - related parties | 7,305 | 3,315 |
| Liability forgiveness | (20,000) | 0 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | 10,000 | (35,000) |
| Accounts payable | 7,500 | (58,967) |
| Net cash used in operating activities | (60,325) | (116,515) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Advances from related parties | 59,875 | 116,065 |
| Net cash provided by financing activities | 59,875 | 116,065 |
| Net change in cash | (450) | (450) |
| Cash at beginning of period | 4,098 | 476 |
| Cash at end of period | 3,648 | 26 |
| SUPPLEMENTAL CASH FLOW INFORMATION: | ||
| Cash paid for income taxes | 0 | 0 |
| Cash paid for interest | $ 0 | $ 0 |
Condensed Balance Sheets - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Current Assets | ||
| Cash | $ 3,648 | $ 4,098 |
| Prepaid expenses | 0 | 10,000 |
| Total Current Assets | 3,648 | 14,098 |
| TOTAL ASSETS | 3,648 | 14,098 |
| Current Liabilities | ||
| Accounts payable | 63,050 | 55,550 |
| Deferred revenue | 0 | 20,000 |
| Due to related parties | 385,387 | 325,512 |
| Total Current and Total Liabilities | 448,437 | 401,062 |
| Stockholders' Deficit | ||
| Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding | 0 | 0 |
| Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding | 60,042 | 60,042 |
| Additional paid-in capital | 32,319,240 | 32,311,935 |
| Accumulated deficit | (32,824,071) | (32,758,941) |
| Total Stockholders' Deficit | (444,789) | (386,964) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 3,648 | $ 14,098 |